Resource Logo
Gay Men's Health Crisis

TREATMENT BRIEFS: ddC Ready for FDA-Approval


GMHC Treatment Issues 1991 Dec 15; 5(9): 5

On Halloween, 1991, Hoffmann-LaRoche announced the completion of the New Drug Application filing process for ddC (trade name HIVID). The company is seeking approval for the treatment af HIV-infected persons who have failed or are intolerant to AZT. Additionally, the company is seeking approval of ddC as a first line therapy for HIV in combination with AZT.

Copyright (c) 1991 - Gay Men's Health Crisis. Non-commercial reproduction encouraged. Distributed by AEGIS, your online gateway to a world of people, knowledge, and resources. Direct Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet: www:


Copyright © 1991 -Gay Men's Health Crisis, Publisher. All rights reserved to Gay Men's Health Crisis (GMHC) Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, INC. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011 Email GMHC. Visit GMHC

Information in this article was accurate in December 15, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.